author-photo

Klaus Podar

Harvard University
Heidelberg University
University of Health Sciences Antigua

233

Papers

12594

Citations

Citation Trend

Filter By

Papers (178) Sort By

Journal Conference Others

OAB-030: Combined targeting of distinct c-Myc and JunB transcriptional programs induces synergistic anti-myeloma activity

2021 Clinical Lymphoma, Myeloma & Leukemia
Show All
- Source
- Cite
- Save
Citations (0)
Effect of cachexia on bone turnover in cancer patients: a case-control study

2021 BMC Cancer
Show All
- Source
- Cite
- Save
Citations (0)
P-082: Delineating CDK9- regulated molecular events for the development of rationally derived multiple myeloma treatment strategies

2021 Clinical Lymphoma, Myeloma & Leukemia
Show All
- Source
- Cite
- Save
Citations (0)
Pathway-Directed Therapy in Multiple Myeloma

2021 Cancers
Show All
- Source
- Cite
- Save
Citations (2)
Composition of the Immune Environment at Baseline Correlates with Time to Response and Treatment Outcome in Newly Diagnosed Transplant-Ineligible Multiple Myeloma (MM) Patients Randomized to Krd or Ktd Followed By Carfilzomib Maintenance or Observation (AGMT_MM 02 Study)

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Publisher Correction: JunB is a key regulator of multiple myeloma bone marrow angiogenesis.

2021 Leukemia
Show All
- Source
- Cite
- Save
Citations (0)
Evaluation of Antibody Responses to COVID-19 Vaccines among Solid Tumor and Hematologic Patients

2021 Cancers
Show All
- Source
- Cite
- Save
Citations (1)
JunB is a key regulator of multiple myeloma bone marrow angiogenesis.

2021 Leukemia
Show All
- Source
- Cite
- Save
Citations (3)
The Role of AP-1 Transcription Factors in Plasma Cell Biology and Multiple Myeloma Pathophysiology

2021 Cancers
- Fengjuan Fan
- Klaus Podar
Show All
- Source
- Cite
- Save
Citations (1)
Selinexor for the treatment of multiple myeloma

2020 Expert Opinion on Pharmacotherapy
Show All
- Source
- Cite
- Save
Citations (19)